Home

Anti-Aging

Navigation

Anti-Aging » Anti-Aging and Medical Conditions » Alzheimers » Memory Pharma, Roche amend agreement

Biopharmaceutical company Memory Pharmaceuticals Corp. said Friday that Swiss drug maker Roche Holding AG has reconsidered its development of two possible Alzheimer's disease treatments it licensed under a 2002 ...

Original Article: Memory Pharma, Roche amend agreement

Continue Reading: 1 2 3 4 5

Email This Article

Post Your Comment

Print This Article

Peer Rating System: Would you recommend this article?
No I wouldn't 1 2 3 4 5 Yes I Would
0.00 out of 5, With 0 Votes

Category Articles

Week of 18 January 2002
Business news in brief from around New Jersey
What It Looks Like: Wolf Blitzer's Dopp Kit (Reg Req'd
Fight against bioterrorism frozen in bureaucratic time
How prepared are we?
Medarex to begin tests for anthrax treatment (Reg Req'd)
N.C. senator says he's working to redesign Project BioShiel
Two Persons Under Medical Treatment For Anthrax In Konya
Working to solve anthrax riddle
Anthrax vaccination starts in Caprivi

Nav: [ 1 2 3 4 5 >> ]

Site Tree | Disclaimer
Link Index | Resources | More Resources

What is Anti-Aging, Anti-Ageing or Antiaging?

Home

Anti-Aging

Anti-Aging Information Partners

Anti-Aging Conferences

Anti-Aging Books

Anti-Aging Extras

Syndicate

Tools

No I wouldn't 1 2 3 4 5 Yes I Would

What is Anti-Aging, Anti-Ageing or Antiaging?

We are not affiliated with the American Academy for Anti-Aging Medicine (A4M)